Effect of statin treatment on metabolites, lipids and prostanoids in patients with Statin Associated Muscle Symptoms (SAMS).
<h4>Background</h4>Between 5-10% of patients discontinue statin therapy due to statin-associated adverse reactions, primarily statin associated muscle symptoms (SAMS). The absence of a clear clinical phenotype or of biomarkers poses a challenge for diagnosis and management of SAMS. Simil...
Main Authors: | Timothy J Garrett, Michelle A Puchowicz, Edwards A Park, Qingming Dong, Gregory Farage, Richard Childress, Joy Guingab, Claire L Simpson, Saunak Sen, Elizabeth C Brogdon, Logan M Buchanan, Rajendra Raghow, Marshall B Elam |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2023-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0294498 |
Similar Items
-
Effect of statin treatment on metabolites, lipids and prostanoids in patients with Statin Associated Muscle Symptoms (SAMS)
by: Timothy J. Garrett, et al.
Published: (2023-01-01) -
Skeletal muscle mitochondrial capacity in patients with statin-associated muscle symptoms (SAMS)
by: Paul D Thompson, et al.
Published: (2024-02-01) -
Statins and bone: myth or reality?
by: Edwards, C, et al.
Published: (2001) -
Pleotropic effects of statins: the dilemma of wider utilization of statin
by: Ambika Choudhary, et al.
Published: (2023-01-01) -
Prescribing statins.
by: Aronson, J
Published: (2005)